本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kiora Pharmaceuticals

2.67
+0.07002.69%
盤後2.58-0.0880-3.30%16:24 EDT
成交量:2.00萬
成交額:5.33萬
市值:1,183.45萬
市盈率:-1.11
高:2.70
開:2.65
低:2.63
收:2.60
52周最高:2.95
52周最低:1.76
股本:443.24萬
流通股本:385.25萬
量比:1.07
換手率:0.52%
股息:- -
股息率:- -
每股收益(TTM):-2.4100
每股收益(LYR):-2.6400
淨資產收益率:-56.36%
總資產收益率:-21.92%
市淨率:0.70
市盈率(LYR):-1.01

資料載入中...

2023/06/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/07

重要事件披露

Form 8-K - Current report
2023/06/01

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/05/31

SEC問詢函

Form CORRESP - Correspondence
2023/05/31

SEC問詢函

Form CORRESP - Correspondence
2023/05/24

SEC問詢函

Form CORRESP - Correspondence
2023/05/24

SEC問詢函

Form CORRESP - Correspondence
2023/05/23

SEC問詢函

Form CORRESP - Correspondence
2023/05/15

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/05/12

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/09

重要事件披露

8-K - Current report
2023/05/05

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2023/04/27

重要事件披露

8-K - Current report
2023/03/30

重要事件披露

8-K - Current report
2023/03/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/23

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals